Addressing Concerns for Successful Implementation of National Health Insurance in South Africa

By HEOR Staff Writer

May 10, 2023

Addressing Concerns for Successful Implementation of National Health Insurance in South Africa: Perspectives from Policymakers and the Role of Pharmacists in Primary Healthcare Re-engineering

In this study, policymakers in South Africa were interviewed to gain insights into their perspectives on the implementation of National Health Insurance (NHI) and the role of pharmacists in primary healthcare (PHC) re-engineering.

The study identified several concerns that could compromise the efficient functionality of NHI and attaining universal healthcare (UHC). These concerns included the need for appropriate governance and regulatory mechanisms, the complexity of issues experienced at local levels of care, the involvement of private healthcare providers and the lack of reimbursement mechanisms, the need for stakeholder engagement and communication, and the underutilization of pharmacists in the healthcare system. The study highlights the importance of proactive and positive engagement with key role-players to address these concerns and ensure the successful implementation of NHI and PHC re-engineering in South Africa.

Reference url

Recent Posts

Long-Term Benefits of Composite Treatment Targets in Type 2 Diabetes Management

By HEOR Staff Writer

January 21, 2026

Sustained Composite Treatment Targets Enhance Clinical and Economic Outcomes in Type 2 Diabetes A recent modeling study examines the long-term benefits of achieving
Navigating Economic Resilience Through Life Sciences Investment

By João L. Carapinha

January 20, 2026

Navigating a Leaderless Global Economy Through Life Sciences Investment In an era of deepening geopolitical fragmentation, often termed the G-Zero world, global governments are urged to prioritize bold life sci...
Guiding Principles for Ethical AI Integration in Drug Development

By HEOR Staff Writer

January 19, 2026

Guiding Principles for Ethical AI Integration in Drug Lifecycle The EMA/FDA document provides a foundational framework for ethical AI integration into drug development, emphasizing its potential to transform evidence g...